Ventura's permanent interatrial shunt was designed to shunt blood from the left to right atrium to improve symptoms in ...
CSI Focus D-HF provides a comprehensive overview of device-based therapy in heart failure, including advancements in ventricle restoration strategies, device-based strategies to improve cardiac output ...
Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and ...
Brian Fahey explains how Adona Medical uses heat to adjust its novel shape memory nitinol implant without harming heart ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The heart is a ...
GLP-1s are linked to an increase in heart rate and number of ventricular events in patients with heart failure with reduced ejection fraction and implanted cardiac devices.
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global structural heart disease treatment devices market since 2018 and the market is poised to grow by USD 5.61 billion during 2020-2024 at ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Heart failure is notoriously difficult to diagnose and track. Though treatment options are increasing, the mortality rate within the first few years of diagnosis remains high—meaning there’s plenty of ...
CHICAGO, Nov 14 (Reuters) - Patients with mild to moderate heart failure benefited from an implanted Medtronic Inc device that combines a pacemaker to coordinate pumping with a defibrillator that ...
The vascular surgery team at UCSF Health recently became the first among University of California medical centers to implant a Barostim device to treat heart failure. The team implanted the device in ...
NHK has learned that some children with severe heart disease in Japan have died because they were unable to access mechanical blood pumps while waiting for transplants.